Takeda appoints Serina Fischer as General Manager for India

Takeda Pharma has appointed Serina Fischer as its General Manager for India operations.  The appointment is effective as of 1st March, 2022. In her new role, Fischer will lead the company’s business in India, ensuring patient access to the company’s innovative medicines, Takeda Pharma said in a statement.

The statement informed that Fischer has over 17 years of experience in the biopharma industry, with expertise in strategy, sales, marketing and operations. She joined Takeda in 2017 and has held various leadership roles in its US affiliate.

Commenting on her new role, she said in the statement, “I am honoured that the company leadership has entrusted me with this responsibility. With the second-largest population in the world and significant disease burdens in Takeda’s chosen therapy areas, India is a vital market from a geographical standpoint for the company. We remain committed to serving patients in India and providing them enhanced access to our highly innovative medicines locally.”